Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
Demo Company
GLOBETECH PUBLISHING LLC

Blocking Cell Movement Explored to Stop the Spread of Cancer

By BiotechDaily International staff writers
Posted on 14 Jul 2014
Image: Migrating embryonic neural crest cells (Photo courtesy of UCL - University College London).
Image: Migrating embryonic neural crest cells (Photo courtesy of UCL - University College London).
Learning more about how cells travel through the body could lead to innovative new treatments to block cancer cells from metastasizing and causing secondary tumors, according to new research.

Scientists discovered that cells can change into an invasive, liquid-like state to readily move through the thin channels in the human body. This transformation is activated by chemical signals, which could be blocked to stop cancer cells from spreading. Most cancer deaths are not caused by to primary tumors, but to secondary tumors in major organs, such as the lungs or brain, caused by cells moving from the original tumor to other places in the body.

The study led by the University College London (UCL; UK) researchers and published July 8, 2014, in the Journal of Cell Biology, used embryonic cells to better determine how groups of cells move in a developmental process similar to that exploited by cancer to spread around the body. The scientists reported that a molecule called lysophosphatidic acid (LPA) transforms cells from a solid-like to a liquid-like state, allowing cells to flow between normal tissues in the body. They were able to turn off the signals from LPA, stopping the cells from moving down the narrow, blood vessel-like channels.

Lead scientist Prof. Roberto Mayor, from the UCL department of cell and developmental biology, said, “We have found a way to stop the movement of embryonic cells by blocking LPA signals. It is likely that a similar mechanism operates during cancer invasion, which suggests a possible alternative which cancer treatments might work in the future, if therapies can be targeted to limit the tissue fluidity of tumors. Our findings are important for the fields of cell, developmental and cancer biology. Previously, we thought cells only moved around the body either individually or as groups of well-connected cells. What we have discovered is a hybrid state where cells loosen their links to neighboring cells but still move en masse together, like a liquid. Moreover, we can stop this movement.”

Related Links:

University College London



Channels

Genomics/Proteomics

view channel
Image: An activated PTEN dimer that contains two non-mutant proteins (A) can transform the functional lipid (D) on the cellular membrane (E) into a chemical form that tunes down cancer predilection. Dimers that contain a mutated protein (B) or PTEN monomers cannot transform the functional lipid (Photo courtesy of Carnegie Mellon University).

PTEN Requires a Stable Dimer Configuration to Effectively Suppress Tumor Growth

Molecular structural analysis has shown that the PTEN (phosphatase and tensin homolog) tumor suppressor can function effectively only when two wild-type alleles are present to form a stable dimer that... Read more

Lab Technologies

view channel
Image: The ChilliBlock modular system for precise, controlled cooling and heatingof biological samples (Photo courtesy of Asynt).

Modular Cooling/Heating System Safeguards Temperature-Sensitive Biological Samples

A new modular system designed for precise, controlled cooling and heating of biological samples in microplates, vials and Eppendorf tubes is now available for biotech, clinical, and life science laboratories.... Read more

Business

view channel

MS Drug Deal to Net More Than USD 1 Billion

A pharmaceutical company based in Switzerland has purchased the remaining rights to the multiple sclerosis drug Ofatumumab, which will allow it to continue development of the compound for treating relapsing remitting multiple sclerosis (RRMS) and similar autoimmune diseases. Novartis (Basel, Switzerland) recently announced... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.